CINCINNATI, Ohio and LOUISVILLE, Ky. â GBBN is currently fabricating and distributing 650 3D printed face shields to healthcare institutions and nonprofits at the frontline of battling the COVID-19 crisis within Ohio and Kentucky.
âWeâre not typically in the medical supply business,â says GBBN CEO, Matthew Schottelkotte, âbut then our response to the novel coronavirus has our firm doing a lot of new things. Whatâs not new is that this response is rooted in our maker culture.â
The effort to produce the face shields has been headed up by members of GBBNâs 3D Printing Focus Group. In late March, when it became clear that GBBN could help address shortages in medical supplies by 3D printing face shields, the group started working on their own personal 3D printers (or on printers borrowed from the office) to test prototypes from open-source face shield designs.
The first version of the face shield frameâthe piece that sits on the forehead and holds the clear shieldâtook over three hours to print. Several versions of the design were tested before hitting on one that not only worked with the available printers, but also printed quickly enough to allow the group to ramp up production.
With growing concern that aerosolized particles could transmit COVID-19 through the surface of the eye, it was especially important to use a design that shielded medical workersâ eyes from above. âAdding a solid visor panel to the frame would have solved this problem,â says GBBNâs Andrew Campbell, âbut it would have drastically increased print time and lowered production capacity.â
Fortunately, the team figured out that they could laser cut the piece of acetate that formed the plastic shield itself so that, when assembled, it would bend towards its wearerâs forehead and provide the protection that was needed.
Want to 3D print your own face shields? You can download GBBNâs source files here: Single Frame, Stacked Frame (x 4), Stacked Frame (x8), Stacked Frame (x10), Face Shield Laser Cut Pattern.
Read more about GBBNâs response to COVID-19 here.
Add Comment